Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/CYTORI-THERAPEUTICS-INC-8997/news/Cytori-Therapeutics-Announces-Timing-for-Full-Enrollment-in-U-S-Phase-III-Scleroderma-Trial-22246837/?utm_source=whatsapp&utm_medium=social&utm_campaign=share